CAR-T therapy moves beyond cancer, and autoimmune disease becomes the next proving ground
DDDr. Dereck Mush, MD, MBA
Feb 4
What they do
Novocure manufactures the Optune system, which delivers Tumor Treating Fields to disrupt cancer cell division. The wearable therapy is prescribed by oncologists to treat patients diagnosed with glioblastoma and malignant pleural mesothelioma.
The record
- Vertical
- Medical Devices
- Sub-segment
- Cancer therapy systems
- Product type
- Device
- Stage
- Public
- Headquarters
- Root, Switzerland
- Region
- Europe
- Founded
- 2000
- Total funding
- $100M raised
Notable investors: Johnson & Johnson Development Corporation, Pfizer, Index Ventures.
Also in Medical Devices
Related on The Signal
A CDMO partnership shows how gene therapy manufacturing is scaling for chronic disease
DDDr. Dereck Mush, MD, MBA
Sep 3Liquid biopsy monitoring is turning precision oncology into a continuous process, not a one time test
DDDr. Dereck Mush, MD, MBA
Jun 10
PATHFINDER 2 Results: What the Galleri Multi-Cancer Blood Test Actually Found
DDDr. Dereck Mush, MD, MBA
Jun 10